Anzeige
❌
Mehr »
Freitag, 30.10.2026 - Börsentäglich über 12.000 News
US-Bann naht: Pentagon sperrt China-Metalle - dieser Nickel-Explorer reagiert
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
JB

WKN: A41ARP | ISIN: NL0015002J37 | Ticker-Symbol: Z98
Tradegate
29.10.26 | 15:37
10,825 Euro
-0,69 % -0,075
1-Jahres-Chart
JBS NV Chart 1 Jahr
5-Tage-Chart
JBS NV 5-Tage-Chart
RealtimeGeldBriefZeit
10,83510,92529.10.
10,81510,98029.10.

Aktuelle News zur JBS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
23.10.JBS N.V.: JBS to Host Third Quarter 2026 Earnings Call on November 10, 2026344JBS N.V. (NYSE: JBS; B3: JBSS32) announced today that it will release its third quarter 2026 financial results after the U.S. market closes on Monday, November 9, 2026. The company's executives...
► Artikel lesen
09.10.Pilgrim's Pride Forms Special Committee To Review Meatpacker JBS Buyout Bid2
09.10.Pilgrim's Pride forms special committee to advise on JBS proposal1
09.10.Pilgrim's Pride board to review takeover approach by Brazil's JBS2
09.10.Pilgrim's Pride Corporation: Pilgrim's Pride Forms Special Committee and Selects Advisors to Review JBS N.V. Proposal431GREELEY, Colo., Oct. 09, 2026 (GLOBE NEWSWIRE) -- The board of directors of Pilgrim's Pride Corporation (NASDAQ: PPC) ("PPC") has formed a special committee of independent and disinterested directors...
► Artikel lesen
JBS Aktie jetzt für 0€ handeln
22.09.JBS shifts Brazilian debt issuance to Dutch parent8
21.09.JBS embraces protein trend with branch-out of Genu-in subsidiary-
15.09.JBS N.V. - 8-K, Current Report4
15.09.Juniper Biosciences Unveils JBS-002 and JBS-004, Advancing Two Late-Stage Diagnostic Programs to Registration Batch Manufacturing in the Fourth Quarter of 2026606Prostate cancer and Alzheimer's disease imaging programs position the Company for FDA submissions in 2027 across two of the fastest-growing segments in molecular imagingBEDMINSTER, N.J., Sept. 15, 2026...
► Artikel lesen
04.09.Trump-Erlass zu Rindfleisch belastet Aktien von JBS und Tyson Foods47
04.09.JBS to ramp up egg production in Brazil2
01.09.Juniper Biosciences: Juniper's JBS-003 (F-MISO) Program Receives FDA Breakthrough Therapy Designation, Advancing a First-in-Class Hypoxia Tracer Enabling Radiation De-escalation in HPV-Positive Head and Neck Cancer654BEDMINSTER, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Juniper Biosciences today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to JBS-003 (18F-fluoromisonidazole...
► Artikel lesen
01.09.JBS co-owner lobbied Trump to lower beef import tariffs, WSJ reports1
25.08.Transcript: JBS Q2 2026 Earnings Conference Call11
24.08.JBS owners buy defense company Avibras2
24.08.UBS raises JBS stock price target on improved 2027-28 outlook8
20.08.JBS Makes New Bid For Full Control, Delisting Of Pilgrim's Pride4
20.08.JBS seeking total control of Pilgrim's Pride Corp.: JBS currently owns approximately 88% of the poultry processor2
20.08.JBS Proposes To Acquire Remaining 18% Of Pilgrim's Pride In All-Stock Deal2
19.08.JBS proposes taking Pilgrim's Pride private1
1 2 3 4 5 Weiter >>
98 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1